Literature DB >> 10026385

The progression of Alzheimer's disease from limbic regions to the neocortex: clinical, radiological and pathological relationships.

Z Nagy1, N J Hindley, H Braak, E Braak, D M Yilmazer-Hanke, C Schultz, L Barnetson, E M King, K A Jobst, A D Smith.   

Abstract

Alzheimer's disease (AD) is characterised by the gradual accumulation of neurofibrillary pathology in selected regions of the brain. Earlier studies indicate that the accumulation of neurofibrillary tangles is associated both with decline in patient's cognitive performance as well as with medial temporal lobe atrophy on CT scans. There are also indications that progression through the pathological stages of AD is associated with decline in cognitive functions. The results of this study indicate that progression of disease, especially beyond the boundaries of the limbic regions, is associated with marked decline in the cognitive performance of patients suffering from AD. However the clinical manifestations of early pathological stages are not so well defined. We also found that the atrophy of the medial temporal lobe on CT scans is related to the progression of pathology. Atrophy is most apparent when the disease reaches its isocortical stages and is not marked in the limbic stages of the disease. The additive effect of pathologies co-existing with AD is apparent in reduced cognitive scores, while the atrophy of limbic structures, as measured on CT scans, seems to be mainly attributable to AD-related pathology.

Entities:  

Mesh:

Year:  1999        PMID: 10026385     DOI: 10.1159/000017111

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  18 in total

1.  Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment.

Authors:  Charles B Malpas; Michael M Saling; Dennis Velakoulis; Patricia Desmond; Terence J O'Brien
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Alzheimer's disease and frontal variant of frontotemporal dementia-- a very brief battery for cognitive and behavioural distinction.

Authors:  Roberta Perri; Giacomo Koch; Giovanni A Carlesimo; Laura Serra; Lucia Fadda; Patrizio Pasqualetti; Carla Pettenati; Carlo Caltagirone
Journal:  J Neurol       Date:  2005-05-23       Impact factor: 4.849

Review 3.  Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Authors:  Peter T Nelson; Elizabeth Head; Frederick A Schmitt; Paulina R Davis; Janna H Neltner; Gregory A Jicha; Erin L Abner; Charles D Smith; Linda J Van Eldik; Richard J Kryscio; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-04-24       Impact factor: 17.088

4.  Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype.

Authors:  Kelly L Lange; Mark W Bondi; David P Salmon; Douglas Galasko; Dean C Delis; Ronald G Thomas; Leon J Thal
Journal:  J Int Neuropsychol Soc       Date:  2002-11       Impact factor: 2.892

5.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia.

Authors:  C R Jack; D W Dickson; J E Parisi; Y C Xu; R H Cha; P C O'Brien; S D Edland; G E Smith; B F Boeve; E G Tangalos; E Kokmen; R C Petersen
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

Review 6.  Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2011-02       Impact factor: 3.911

7.  Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease.

Authors:  Maria Vittoria Spampinato; Zoran Rumboldt; Robert J Hosker; Jacobo E Mintzer
Journal:  Radiology       Date:  2010-12-16       Impact factor: 11.105

8.  Neuropathological basis of magnetic resonance images in aging and dementia.

Authors:  William J Jagust; Ling Zheng; Danielle J Harvey; Wendy J Mack; Harry V Vinters; Michael W Weiner; William G Ellis; Chris Zarow; Dan Mungas; Bruce R Reed; Joel H Kramer; Norbert Schuff; Charles DeCarli; Helena C Chui
Journal:  Ann Neurol       Date:  2008-01       Impact factor: 10.422

9.  Neuropsychological patterns in magnetic resonance imaging-defined subgroups of patients with degenerative dementia.

Authors:  John Listerud; Chivon Powers; Peachie Moore; David J Libon; Murray Grossman
Journal:  J Int Neuropsychol Soc       Date:  2009-05       Impact factor: 2.892

Review 10.  The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.

Authors:  Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.